Saccharomyces cerevisiae oesophagitis in a patient with oesophageal carcinoma

Saccharomyces species are emerging opportunistic fungal pathogens that can cause bloodstream infections in humans. These infections have often been associated with the ingestion of probiotics. Saccharomyces oesophagitis is a rare condition which has been described so far in only two publications. H...

Full description

Saved in:
Bibliographic Details
Main Authors: Dimas Alexandre Kliemann, Vicente Sperb Antonello, Luis Carlos Severo, Alessandro Comarú Pasqualotto
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2011-06-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/1630
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Saccharomyces species are emerging opportunistic fungal pathogens that can cause bloodstream infections in humans. These infections have often been associated with the ingestion of probiotics. Saccharomyces oesophagitis is a rare condition which has been described so far in only two publications. Here we report the case of a patient who was diagnosed with Saccharomyces oesophagitis. The clinical picture was indistinguishable from that of Candida oesophagitis. The Saccharomyces isolate was shown to be susceptible to fluconazole by both CLSI M27-A and disk diffusion methods. In contrast to cases of fungaemia, Saccharomyces oesophagitis does not seem to follow probiotic use. Due to the potential for antifungal resistance among emerging fungal pathogens, proper mycological identification at the species level is essential.
ISSN:1972-2680